Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Boric Acid SCHEMBL217254 | 0.81 | HTR1A (0.33) | KDM4EALDH1A1 | |
| Boric Acid SCHEMBL17857654 | 0.79 | — | — | |
| Boric Acid SCHEMBL14841786 | 0.79 | — | — | |
| Trimethylammonium SCHEMBL217135 | 0.78 | — | — | |
| Boric Acid SCHEMBL216470 | 0.78 | CA12 (0.33) | KDM4EMAPTTHRBMAPK1TDP1 | |
| Boric Acid SCHEMBL217449 | 0.78 | LMNA (0.33) | TDP1 | |
| Boric Acid SCHEMBL6277854 | 0.78 | LMNA (0.33) | TDP1 | |
| Boric Acid SCHEMBL5074757 | 0.78 | LMNA (0.33) | TDP1 | |
| Boric Acid SCHEMBL11515716 | 0.78 | ALDH1A1 (0.33) | KDM4EMEN1ALDH1A1POLBMAPT | |
| Boric Acid SCHEMBL7102036 | 0.78 | ALDH1A1 (0.33) | KDM4EMEN1ALDH1A1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 829 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-19 | — | — | US | claimed |
| EP-4196507-A1 | CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| EP-4103631-A1 | ETHYLENE-ALPHA-OLEFIN-DIENE MONOMER COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103630-A1 | PROPYLENE COPOLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103628-A1 | PROPYLENE POLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4017887-A1 | ISOTACTIC PROPYLENE HOMOPOLYMERS AND COPOLYMERS PRODUCED WITH C1 SYMMETRIC METALLOCENE CATALYSTS | ExxonMobil Chemical Patents Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| EP-4007780-A1 | METALLOCENES AND METHODS THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-06-08 | — | — | EP | claimed |
| EP-3956370-A1 | METALLOCENES WITH TWO -SI-SI-BRIDGES | ExxonMobil Chemical Patents Inc. (US) | 2022-02-23 | — | — | EP | claimed |
| US-11254763-B2 | Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-02-22 | — | — | US | claimed |
| WO-2022035585-A1 | CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-02-17 | — | — | WO | claimed |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| EP-1546223-A2 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | ExxonMobil Chemical Patents Inc. (US) | 2005-06-29 | — | — | EP | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040266961-A1 | Catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004106390-A2 | POLYMERIZATION AND OLIGOMERIZATION CATALYST WITH TRIDENTATE OR TETRADENTATE LIGAND | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-12-09 | — | — | WO | claimed |
| WO-2004026923-A9 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEM PATENTS INC (US) | 2004-09-10 | — | — | WO | claimed |
| US-20040122191-A1 | Supercritical polymerization process and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC | 2004-06-24 | — | — | US | claimed |
| WO-2004026923-A2 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | ODC1, DDT, OXGR1 | KDM4E 3042/4885MEN1 1775/4885ALDH1A1 189/4885 |
| US-11254763-B2 | Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization | CCNT1, CCNA1, CCNE2 | KDM4E 1895/4885MEN1 2396/4885ALDH1A1 1174/4885 |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | PYM1, ZNF207, POLL | KDM4E 1418/4885MEN1 521/4885ALDH1A1 4206/4885 |
| US-20040266961-A1 | Catalyst composition II | MLX, CBX2, BMX | KDM4E 1089/4885MEN1 1095/4885ALDH1A1 4593/4885 |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | CCRL2, ARL1, OSBP2 | KDM4E 3216/4885MEN1 1786/4885ALDH1A1 4248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.